TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
2.100
+0.020 (0.96%)
At close: Jan 13, 2026, 4:00 PM EST
2.120
+0.020 (0.95%)
After-hours: Jan 13, 2026, 7:18 PM EST
TherapeuticsMD Market Cap
TherapeuticsMD has a market cap or net worth of $24.31 million as of January 13, 2026. Its market cap has increased by 92.91% in one year.
Market Cap
24.31M
Enterprise Value
23.67M
1-Year Change
92.91%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since April 23, 2013, TherapeuticsMD's market cap has decreased from $204.60M to $24.31M, a decrease of -88.12%. That is a compound annual growth rate of -15.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 24.30M | 28.57% |
| Dec 31, 2025 | 18.90M | 90.91% |
| Dec 31, 2024 | 9.90M | -58.40% |
| Dec 29, 2023 | 23.80M | -55.01% |
| Dec 30, 2022 | 52.90M | -64.99% |
| Dec 31, 2021 | 151.10M | -54.23% |
| Dec 31, 2020 | 330.10M | -49.70% |
| Dec 31, 2019 | 656.20M | -27.60% |
| Dec 31, 2018 | 906.30M | -30.67% |
| Dec 29, 2017 | 1.31B | 15.24% |
| Dec 30, 2016 | 1.13B | -38.50% |
| Dec 31, 2015 | 1.84B | 165.63% |
| Dec 31, 2014 | 694.30M | -8.08% |
| Dec 31, 2013 | 755.30M | 269.16% |
| Apr 23, 2013 | 204.60M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.91B |
| Johnson & Johnson | 505.28B |
| AbbVie | 388.90B |
| UnitedHealth Group | 308.45B |
| AstraZeneca | 294.97B |
| Novartis AG | 274.30B |
| Merck & Co. | 271.01B |
| Novo Nordisk | 263.26B |